My Portfolio

Harvard Bioscience Inc HBIO:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD

Last | 4:00 PM EDT

6.50

+0.04 (+0.62%)

Volume

28,120

52 week range

3.70 - 9.40

Open6.51
Day High6.60
Day Low5.87
Prev Close6.46
52 Week High9.40
52 Week High Date10/30/25
52 Week Low3.70
52 Week Low Date06/04/25

Latest On Harvard Bioscience Inc

Epstein files: Yale bars prof from teaching amid review of emails February 11, 2026CNBC.com
How to become 'time rich,' from a self-made millionaireJanuary 7, 2026CNBC.com
Summers takes leave at Harvard, resigns OpenAI board seat after Epstein email furorNovember 19, 2025CNBC.com
Teens are using AI for homework—and experts warn it could rewire their brainsOctober 12, 2025CNBC.com
Judge voids $2.2 billion Harvard funding freeze by Trump administrationSeptember 3, 2025CNBC.com
Reich, Reinhart, Booth warn tariff uncertainty hurts U.S. companies and shoppersAugust 22, 2025CNBC.com
These 10 states offer the most stable housing markets in AmericaJuly 17, 2025CNBC.com
Republicans move to cut payment pauses for struggling student loan borrowersJune 17, 2025CNBC.com

Key Stats

Market Cap29.316M
Shares Out4.51M
10 Day Average Volume0.03M
Dividend-
Dividend Yield-
Beta1.50

Latest On Harvard Bioscience Inc

Epstein files: Yale bars prof from teaching amid review of emails February 11, 2026CNBC.com
How to become 'time rich,' from a self-made millionaireJanuary 7, 2026CNBC.com
Summers takes leave at Harvard, resigns OpenAI board seat after Epstein email furorNovember 19, 2025CNBC.com
Teens are using AI for homework—and experts warn it could rewire their brainsOctober 12, 2025CNBC.com
Judge voids $2.2 billion Harvard funding freeze by Trump administrationSeptember 3, 2025CNBC.com
Reich, Reinhart, Booth warn tariff uncertainty hurts U.S. companies and shoppersAugust 22, 2025CNBC.com
These 10 states offer the most stable housing markets in AmericaJuly 17, 2025CNBC.com
Republicans move to cut payment pauses for struggling student loan borrowersJune 17, 2025CNBC.com

KEY STATS

Open6.51
Day High6.60
Day Low5.87
Prev Close6.46
52 Week High9.40
52 Week High Date10/30/25
52 Week Low3.70
52 Week Low Date06/04/25
Market Cap29.316M
Shares Out4.51M
10 Day Average Volume0.03M
Dividend-
Dividend Yield-
Beta1.50

RATIOS/PROFITABILITY

EPS (TTM)-2.20
P/E (TTM)-2.96
Fwd P/E (NTM)-6.31
EBITDA (TTM)5.884M
ROE (TTM)-78.65%
Revenue (TTM)85.531M
Gross Margin (TTM)58.42%
Net Margin (TTM)-11.44%
Debt To Equity (MRQ)360.45%

EVENTS

Earnings Date08/10/2026(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Content From Our Affiliates

Harvard Bioscience Shareholders Expand Equity Plans, Elect DirectorsJune 2, 2026TipRanks
Harvard Bioscience Balances Margin Gains With Soft SalesMay 19, 2026TipRanks
Harvard Bioscience Earnings Call Highlights Gradual RecoveryMay 12, 2026TipRanks
Harvard Bioscience reports Q1 adjusted EPS (33c) vs. ($1.25) last yearMay 12, 2026TipRanks
Harvard Bioscience reiterates Q2 revenue view $20.5M-$22.5MMay 12, 2026TipRanks

Profile

Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, drug and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. The Company’s products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and...

John Duke

President, Chief Executive Officer, Director

Mark Frost

Chief Financial Officer, Treasurer

Address

84 OCTOBER HILL RD

Holliston, MA

01746-1371

United States

https://www.harvardbioscience.com/